Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways
Featured Clinical Focus
AMLBiomarker-Driven Lung CancerBone Marrow & SCTBTK Inhibitors: In-FocusCAR T-Cell TherapyChronic Lymphocytic LeukemiaEGFR-Positive Lung CancerEndometrial CancerFollicular LymphomaHCCLung CancerMantle Cell LymphomaMPNsMultiple MyelomaRenal Cell CarcinomaSmall Cell Lung CancerThyroid Cancers
Clinical Focus
View MoreBrain CancerBreast CancerGastrointestinal CancerGenitourinary CancersGynecologic CancersHead & Neck CancersHematologyLeukemiasLung CancerLymphomasMelanomaSarcomaSkin CancersThyroid Cancers
NEWS
All NewsClinical FocusSpecial Reports
CONFERENCES
Conference CoverageConference Listing
MEDIA
All VideosCase-Based Peer PerspectivesExpert Perspective Virtual Tumor BoardInterviewsInvestigator PerspectivesMedical World NewsPodcastsPrecision Medicine
PUBLICATIONS
All PublicationsEvolving ParadigmsRoundtable Meetings SpotlightTargeted Therapies in Oncology
CME/CE
RESOURCES
Case-Based Roundtable SeriesClinical TrialsPartnersPrecision Medicine PerspectivesPress ReleasesSponsored ContentTreatment Resources
SUBSCRIBE
eNewsletter
  • About Us
  • Advertise
  • Contact Us
  • CureToday.com
  • CancerNetwork.com
  • OncLive.com
  • OncNursingNews.com
  • Do Not Sell My Information
  • Privacy
  • Terms & Conditions
  • MJHLS Brand Logo

© 2023 MJH Life Sciences and Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways. All rights reserved.

Advertisement
Featured Clinical Focus
  • AML
  • Biomarker-Driven Lung Cancer
  • Bone Marrow & SCT
  • BTK Inhibitors: In-Focus
  • CAR T-Cell Therapy
  • Chronic Lymphocytic Leukemia
  • EGFR-Positive Lung Cancer
  • Endometrial Cancer
  • Follicular Lymphoma
  • HCC
  • Lung Cancer
  • Mantle Cell Lymphoma
  • MPNs
  • Multiple Myeloma
  • Renal Cell Carcinoma
  • Small Cell Lung Cancer
  • Thyroid Cancers
Clinical FocusSee All >
  • Brain Cancer
  • Breast Cancer
  • Gastrointestinal Cancer
  • Genitourinary Cancers
  • Gynecologic Cancers
  • Head & Neck Cancers
  • Hematology
  • Leukemias
  • Lung Cancer
  • Lymphomas
  • Melanoma
  • Sarcoma
  • Skin Cancers
  • Thyroid Cancers
baltimore conference logo
  • About Us
  • Advertise
  • Contact Us
  • CureToday.com
  • CancerNetwork.com
  • OncLive.com
  • OncNursingNews.com
  • Do Not Sell My Information
  • Privacy
  • Terms & Conditions
  • MJHLS Brand Logo

© 2023 MJH Life Sciences™ , Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways. All rights reserved.

A 67-Year-Old Man with Chronic Lymphocytic Leukemia

John Allan, MD, reviews the diagnosis and treatment of a 67-year-old man with chronic lymphocytic leukemia while highlighting potential treatment options.

EP. 1: Case Presentation: A 67-Year-Old Man with Chronic Lymphocytic Leukemia

December 17th 2021

John Allan, MD, presents and reviews the case of a 67-year-old man with chronic lymphocytic leukemia.

EP. 2: Testing and Risk Stratification in CLL

December 17th 2021

A key opinion leader shares insight into testing and risk stratification for chronic lymphocytic leukemia.

EP. 3: First-Line Therapy Options in CLL

December 17th 2021

John Allan, MD, highlights treatment options in the first-line setting for chronic lymphocytic leukemia.

EP. 4: Chronic Lymphocytic Leukemia: RESONATE-2 Trial

December 20th 2021

A leukemia specialist details the Resonate-2 clinical trial studying BTK inhibitor ibrutinib.

EP. 5: Comparing BTK Inhibitors in CLL Treatment

December 20th 2021

John Allan, MD, compares the available approved BTK inhibitors for treating chronic lymphocytic leukemia.

EP. 6: Treatment Approaches for High-Risk Chronic Lymphocytic Leukemia

December 20th 2021

An expert describes various treatment approaches for patients with high-risk chronic lymphocytic leukemia.

EP. 7: The Future of Chronic Lymphocytic Leukemia Treatment

December 20th 2021

John Allan, MD, looks to the future of chronic lymphocytic leukemia treatments.

Advertisement
Advertisement